These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31173299)

  • 1. MiR-154 inhibits cells proliferation and metastasis in melanoma by targeting AURKA and serves as a novel prognostic indicator.
    Wang J; Fang Y; Liu YF; Wang X; Wang XL; Wang RY; Meng ZD
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4275-4284. PubMed ID: 31173299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-431 is a prognostic marker and suppresses cell growth, migration and invasion by targeting NOTCH2 in melanoma.
    Sun YW; Li XH; Wang H; Wu J
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3876-3884. PubMed ID: 31115015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA.
    Yuan Q; Sun T; Ye F; Kong W; Jin H
    Cancer Biomark; 2017; 19(1):93-101. PubMed ID: 28269755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A.
    Chang X; Zhang H; Lian S; Zhu W
    Biochem Biophys Res Commun; 2016 Jul; 475(3):251-6. PubMed ID: 27233613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7.
    Wu J; Li J; Ren J; Zhang D
    Biomed Pharmacother; 2017 Jun; 90():303-310. PubMed ID: 28364602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
    Huang Y; Xiao W; Jiang X; Li H
    Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma.
    Li J; Liu X; Li C; Wang W
    J Cell Biochem; 2019 Aug; 120(8):12412-12421. PubMed ID: 30825222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82.
    Long J; Luo J; Yin X
    Biomed Pharmacother; 2018 Jun; 102():1195-1202. PubMed ID: 29710538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497.
    Bai J; Zhao WY; Li WJ; Ying ZW; Jiang DQ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3410-3420. PubMed ID: 31081095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of FLOT2 as a novel target for microRNA-34a in melanoma.
    Liu R; Xie H; Luo C; Chen Z; Zhou X; Xia K; Chen X; Zhou M; Cao P; Cao K; Zhou J
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):993-1006. PubMed ID: 25403318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
    Bai J; Zhang Z; Li X; Liu H
    Cancer Biomark; 2015; 15(5):599-608. PubMed ID: 26406949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
    Li J; Zou X
    Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA DSCAM-AS1 is associated with poor clinical prognosis and contributes to melanoma development by sponging miR-136.
    Huang YL; Xu Q; Wang X
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2888-2897. PubMed ID: 31002140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
    Xue KC; Hu DD; Zhao L; Li N; Shen HY
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma.
    Zhao CC; Guo H; Wang Y; Li JH
    Hum Cell; 2021 Mar; 34(2):654-666. PubMed ID: 33400243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 18. Down-regulated expression of miR-582 predicts poor prognosis and facilitates melanoma progression by targeting FOXC1.
    Chen F; Zhang D
    Arch Dermatol Res; 2022 Oct; 314(8):759-766. PubMed ID: 34628519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells.
    Komina A; Palkina N; Aksenenko M; Tsyrenzhapova S; Ruksha T
    PLoS One; 2016; 11(12):e0168229. PubMed ID: 28005927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.